Uses and misuses of quantitative ultrasonography in managing osteoporosis

E. Michael Lewiecki, MD
Osteoporosis Director, New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM

Bradford Richmond, MD
Department of Radiology, Cleveland Clinic; certification instructor, International Society for Clinical Densitometry

Paul D. Miller, MD
Medical Director, Colorado Center for Bone Research, Lakewood, CO

Address: E. Michael Lewiecki, MD, 300 Oak St. NE, Albuquerque, NM 87106; e-mail lewiecki@aol.com

Dr. Lewiecki has indicated that he has received grant or research support from the Amgen, Aventis, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Procter and Gamble, Roche, and Wyeth-Ayerst corporations; has served as a consultant, on the advisory board, speakers’ bureau, or at sponsored speaking events for the Amgen, Aventis, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Procter and Gamble, Roche, Servier, and Wyeth-Ayerst corporations; and is a direct stock shareholder in the General Electric corporation.

Dr. Richmond has indicated that he has received grant or research support from the Aventis corporation and served as a consultant or on the speakers’ bureau of the Merck and Procter and Gamble corporations.

Dr. Miller has indicated that he has received scientific grants from the Amgen, Aventis, Eli Lilly, Merck, Novartis, Pfizer, Pharmacia, Procter and Gamble, and Roche corporations and has served on the speakers’ bureau, advisory board, or as a consultant for the Amgen, Aventis, Eli Lilly, GlaxoSmithKline, Merck, Novartis, NPS, Procter and Gamble, and Roche corporations.